Form 4: Precigen Director Fred Hassan Acquires Shares and Stock Units in Lieu of Retainer
SEC Form 4 Filing
Director Fred Hassan acquired shares and restricted stock units of Precigen, Inc. in lieu of an annual retainer.
Summary
- On March 14, 2024, Fred Hassan, a director of Precigen, Inc. (PGEN), acquired 44,055 shares of common stock at a price of $1.43 per share.
- These shares were issued in lieu of an annual retainer of $62,999.
- Hassan also acquired 87,412 restricted stock units (RSUs), each representing a contingent right to receive one share of Precigen common stock, which vest in full on March 14, 2025.
- Additionally, Hassan acquired an option to purchase 101,626 shares of common stock at an exercise price of $1.43, expiring on March 14, 2034.
- Following these transactions, Hassan beneficially owns 1,029,834 shares of Precigen common stock and 87,412 restricted stock units.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of insider transactions. The director's acquisition of shares could be interpreted as a positive sign, but it's also part of their compensation.
Positives
- The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future prospects.
- The issuance of shares in lieu of a retainer preserves the company's cash reserves.
Future Outlook
The document does not contain specific forward-looking statements regarding the company's future performance, but the vesting of RSUs in March 2025 is a future event.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors and their holdings in the company's stock.
Comparison to Industry Standards
- Director compensation packages often include a mix of cash, stock options, and restricted stock units.
- The vesting schedule of the RSUs (one year) is fairly standard.
- The option exercise price being equal to the market price at the time of grant is also a common practice.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment if viewed as a sign of confidence by a company director.
Key Dates
| Date | Description |
|---|---|
| 03/14/2024 | Date of transaction: acquisition of common stock, restricted stock units, and option to purchase common stock. |
| 03/14/2025 | Vesting date for the 87,412 restricted stock units. |
| 03/14/2034 | Expiration date for the option to purchase 101,626 shares of common stock. |
| 03/18/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.